Lieberman examined the self-reported incidence of lung infections in patients with genetic AAT deficiency, and noted three to five lung infections per year in AAT deficient patients not receiving AAT replacement therapy (72). Here, SERPINA1 is linked to alpha 1-antitrypsin deficiency.